• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006

  • in Cardiovascular
  • — 13 Nov, 2006
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
AudioMedica News
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-210"/>
Oscar Marroquin
Oscar Marroquin
Sanjay Kaul
Sanjay Kaul
Joseph Sweeny
Joseph Sweeny
Maximo Rivero-Ayerza
Maximo Rivero-Ayerza

Repeat Revascularization With Drug Eluting versus Bare Metal Stents

REFERENCE: American Heart Association Scientific Sessions, Chicago, November 12-15, 2006. Abstract 1948 (C 206) Page: 236, Sunday 12th
OSCAR C MARROQUIN, University of Pittsburgh
Although drug eluting stents reduce the need for repeat revascularization, the timing of stent failure is less predictable than with bare metal stents. This is the finding of a study using data from the National Heart Lung and Blood Institute Dynamic Registry. Oscar Marroquin told the Chicago conference about the comparison his group has made between different waves of patients having angioplasty before and after the adoption of drug eluting stents.

Are Drug Eluting Stents Really Worth the Money?

REFERENCE: American Heart Association Scientific Sessions, Chicago, November 12-15, 2006. Abstract: 1949 (C207) Sunday page: 236
SANJAY KAUL, Cedars-Sinai Medical Center, Los Angeles
A strategy of unconditional substitution of bare metal with drug eluting stents is not cost-worthy, according to a study from Sanjay Kaul who recommended to delegates at the AHA conference that more selective use of drug eluting stents should be applied in the cath lab.

Cardiac Alllograft Patients: Drug Eluting Stents Better, But Not as Good as Hoped

REFERENCE: American Heart Association Scientific Sessions, Chicago, November 12-15, 2006. Abstract 1957 C215 Sunday page 236
JOSEPH SWEENY, Mount Sinai School of Medicine, New York
The superiority of drug-eluting over bare metal stents has been confirmed among heart transplant patients, but the benefit does not seem to be as great as has been hoped. Joseph Sweeny told AHA delegates what his group found from their study and what the implications might be.

Atrial Fibrilation An Independent Predictor of Mortality. Euro Heart Failure Survey Results: A Retrospective Analysis

American Heart Association Scientific Sessions 2006 November 12-15th Chicago, Illinois. Abstract: 2013 Page 242 Sunday Oral Session
MAXIMO RIVERO-AYERZA, Erasmus Medical Centre, Rotterdam, The Netherlands
Don’t under-estimate new onset atrial fibrillation in your patients admitted with heart failure: so said Maximo Rivero-Ayerza, who’s found a significant contribution of AF to subsequent mortality.

[audio:https://www.audiomedica.com/podcasting/aha/061113AHA1stPodcast.mp3]

You may also like...

  • Deepak Bhatt SAVOR-TIMI 53 study: saxagliptin had better glucose control than placebo but no cardiovascular benefit 22 Sep, 2013
  • Rapid Genotype Assay for Individualized Warfarin Dosing Rapid Genotype Assay for Individualized Warfarin Dosing 25 Mar, 2007
  • Thrombectomy For Acute Stroke: Results of the Multi MERCI Trial Thrombectomy For Acute Stroke: Results of the Multi MERCI Trial 10 Feb, 2007
  • Telomere Length Predicts Coronary Heart Disease Risk and Statin Response Telomere Length Predicts Coronary Heart Disease Risk and Statin Response 19 Jan, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Audio Journal of Global Health Issues: Anaemia: Towards Oral Therapy: New Targeted Strategies for Stimulating Erythropoiesis
  • Next story Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Childhood Obesity—Whose Business Is It?
    • CT Screening Cuts Lung Cancer Deaths 24 Per…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Cardiovascular
  • Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006

© COPYRIGHT 2020 AUDIOMEDICA.COM.